Correlation Between Instil Bio and DiaMedica Therapeutics

Can any of the company-specific risk be diversified away by investing in both Instil Bio and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Instil Bio and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Instil Bio and DiaMedica Therapeutics, you can compare the effects of market volatilities on Instil Bio and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Instil Bio with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Instil Bio and DiaMedica Therapeutics.

Diversification Opportunities for Instil Bio and DiaMedica Therapeutics

0.39

Correlation Coefficient

Instil Bio  DiaMedica Therapeutics

Weak diversification

The 3 months correlation between Instil and DiaMedica is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Instil Bio and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Instil Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Instil Bio are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Instil Bio i.e., Instil Bio and DiaMedica Therapeutics go up and down completely randomly.

Pair Corralation between Instil Bio and DiaMedica Therapeutics

Considering the 90-day investment horizon Instil Bio is expected to generate 1.95 times more return on investment than DiaMedica Therapeutics. However, Instil Bio is 1.95 times more volatile than DiaMedica Therapeutics. It trades about 0.04 of its potential returns per unit of risk. DiaMedica Therapeutics is currently generating about -0.09 per unit of risk. If you would invest  1,899  in Instil Bio on December 29, 2024 and sell it today you would earn a total of  37.00  from holding Instil Bio or generate 1.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Instil Bio  vs.  DiaMedica Therapeutics

Instil Bio

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Instil Bio are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite weak forward indicators, Instil Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.

DiaMedica Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days DiaMedica Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Instil Bio and DiaMedica Therapeutics

The main advantage of trading using opposite Instil Bio and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Instil Bio position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.

The idea behind Instil Bio and DiaMedica Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.